Sign in

CIK 0001137883

  • Non-accelerated filer
  • Smaller reporting company

BRAINSTORM CELL THERAPEUTICS INC.

Sign in to watch
Ticker
BCLI
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
207273918
Phone
+1 201-488-0460
Business address
1325 AVENUE OF AMERICAS, 28TH FLOOR, NEW YORK, NY, 10019
Former names
BRAINSTORM CELL THERAPEUTICS INC, GOLDEN HAND RESOURCES INC, WIZBANG TECHNOLOGIES INC
  1. 4 Derivatives Options or other derivatives
  2. 4 Grant or award See Remarks acquired 35,000 shares (grant or award)
  3. 3 Insider Initial Statement of Ownership
  4. 4 Grant or award Chief Executive Officer acquired 31,185 shares (grant or award)
  5. 4 Open-market buy Director bought 46,779 shares at $12.99 ($607,659)
  6. 4 Open-market buy EVP and COO bought 5,000 shares at $12.95 ($64,740)
  7. 4 Open-market sale Member of 10% owner group sold 71,753 shares at an average $13.39 ($960,656)
  8. 4 Grant or award EVP & Chief Business Officer acquired 10,000 shares (grant or award)
  9. 4 Grant or award EVP, Head Global Clin Research acquired 25,000 shares (grant or award)
  10. 3 Insider Initial Statement of Ownership
  11. 4 Grant or award EVP and COO acquired 50,000 shares (grant or award)
  12. 3 Insider Initial Statement of Ownership
  13. 4 Derivatives Options or other derivatives
  14. 3 Insider Initial Statement of Ownership
  15. 4 Grant or award Director acquired 4,657 shares (grant or award)
  16. 3 Insider Initial Statement of Ownership
  17. 4 Derivatives Options or other derivatives
  18. 4 Grant or award COO and Chief Medical Officer acquired 35,885 shares (grant or award)
  19. 4 Grant or award Director acquired 5,071 shares (grant or award)
  20. 4 Grant or award Director acquired 2,000 shares (grant or award)

Page 5 of 17 · 329 filings